Funding, M&A, exec moves and hiring — matched to your market, with the people to call.See plans →
ScopeSys closes a $1.1 million seed funding round to enhance tools for drugmakers, providing insights into genomic medicines.
PRIVATEAug 13, 2026•2 days ago
Amount Raised
$1.1 Million
Round Type
Seed
Description
Vancouver-based ScopeSys has successfully secured $1.1 million in seed funding. The startup, founded in 2017, aims to improve the development of genomic medicines with its innovative technologies. CEO Padma Kodukula highlights the need for enhanced analytical instruments in the industry. This funding will help accelerate the development of their cutting-edge tools.
Don't miss ScopeSys's next move
Get an email the moment ScopeSys raises, hires an exec, or expands — usually minutes after it happens.
One email per event. Unsubscribe anytime.